[4-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)BENZYL]-METHYLAMINE DIHYDROCHLORIDE
- $45 - $582
- Product name: [4-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)BENZYL]-METHYLAMINE DIHYDROCHLORIDE
- CAS: 1185299-33-5
- MF: C13H19Cl2N3
- MW: 288.22
- EINECS:
- MDL Number:MFCD06800631
- Synonyms:[4-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)BENZYL]-METHYLAMINE DIHYDROCHLORIDE;1-(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-N-methylmethanamine dihydrochloride
4 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
- TRC
Package
- 5mg
- 10mg
- 500mg
- 5g
- ManufacturerCrysdot
- Product numberCD11338664
- Product description1-(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-N-methylmethanaminedihydrochloride 97%
- Packaging5g
- Price$582
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number016274
- Product description[4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzyl]-methylamine dihydrochloride
- Packaging500mg
- Price$184
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD480673
- Product description[4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzyl]-methylamineDihydrochloride
- Packaging5mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD480673
- Product description[4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzyl]-methylamineDihydrochloride
- Packaging10mg
- Price$60
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11338664 | 1-(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-N-methylmethanaminedihydrochloride 97% | 5g | $582 | 2021-12-16 | Buy |
Matrix Scientific | 016274 | [4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzyl]-methylamine dihydrochloride | 500mg | $184 | 2021-12-16 | Buy |
TRC | D480673 | [4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzyl]-methylamineDihydrochloride | 5mg | $45 | 2021-12-16 | Buy |
TRC | D480673 | [4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzyl]-methylamineDihydrochloride | 10mg | $60 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|